ECHO-Chicago: Hepatitis C (Session XXVIII)
At the conclusion of this activity, participatants will be able to:
- Identify patients at-risk for Hepatitis C and the need for testing;
- Describe staging and cirrhosis of the liver;
- Recognize proper treatment options based on genotype.
Director ECHO Chicago
Associate Chair for Clinical Services
Section Chief of Academic Pediatrics
Associate Professor of Pediatrics
Comer Children's Hospital
Assistant Professor of Medicine
University of Chicago
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.